Dyspnea is a common symptom of lung cancer that can impact patient physical, social, and psychological well-being. Study goals were to evaluate quality of life (QOI,) and dyspnea in patients with lung cancer and the relationships between QOL, dyspnea, trait anxiety, and body consciousness. Sociodemographic and cancer related variables (stage, cell type, performance status) were evaluated. 120 outpatients (aged 35-87 yrs) with stage I-IV lung cancer participated in the study. Patients completed 5 questionnaires assessing QOL, dyspnea, trait anxiety, body consciousness, and pain. 87% of Ss experienced dyspnePatients with high dyspneas cores had lower QOL. Dyspnea was worse in men than in women, and there was a trend towards older patients reporting more severe dyspnea than younger patients. There was no difference in dyspnea based on cancer stage, cell type, or performance status. Pain and anxiety scores were higher in patients with high dyspneDyspnea was more severe in patients taking opioid analgesics when compared to non-opioids or no pain medications. No significant association was found between dyspnea, anxiety, and private body consciousness.